SCHEMBL17482835

SCHEMBL17482835

c1ccc(-c2cccc(-c3ccc4c(c3)Oc3ccccc3C43c4ccccc4Oc4cc(-c5ccccn5)ccc43)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.41
RAB9A P51151 5/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
AURKA O14965 1/20 0.39
SMN1; SMN2 Q16637 5/20 0.38
TP53 P04637 4/20 0.38
KDM4E B2RXH2 3/20 0.38
LMNA P02545 2/20 0.38
MAPK1 P28482 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
ALPL P05186 1/20 0.38
HSP90AA1 P07900 1/20 0.38
ALPI P09923 1/20 0.38
ALPG P10696 1/20 0.38
ALOX15 P16050 1/20 0.38
CCR1 P32246 1/20 0.38
HTT P42858 1/20 0.38
CCR5 P51681 1/20 0.38
CCR8 P51685 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17482838 1.00 PDK2 (0.41) PDK2RAB9AMEN1KMT2AAURKA
SCHEMBL17482918 0.92 MEN1 (0.47) RAB9AMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL17482819 0.91 PDK2 (0.40) PDK2RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL17482828 0.91 PDK2 (0.40) PDK2RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL17482774 0.91 PDK2 (0.41) PDK2RAB9AAURKASMN1; SMN2TP53
SCHEMBL17482787 0.91 PDK2 (0.41) PDK2RAB9AAURKASMN1; SMN2TP53
SCHEMBL17482779 0.91 PDK2 (0.45) PDK2RAB9AAURKASMN1; SMN2TP53
SCHEMBL17482788 0.91 PDK2 (0.45) PDK2RAB9AAURKASMN1; SMN2TP53
SCHEMBL17482831 0.90 MEN1 (0.44) PDK2RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL17482837 0.90 MEN1 (0.44) PDK2RAB9AMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160035986-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-02-04 US disclosed
US-20160035986-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160035986-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, CCNA1 PDK2 2404/4885RAB9A 3035/4885MEN1 277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.